Cargando…
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier pha...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911429/ https://www.ncbi.nlm.nih.gov/pubmed/36776259 http://dx.doi.org/10.3389/fcvm.2023.1085824 |
_version_ | 1784884987056619520 |
---|---|
author | Matteo, Serenelli Anna, Cantone Federico, Sanguettoli Daniele, Maio Gioele, Fabbri Beatrice, Dal Passo Rita, Pavasini Elisabetta, Tonet Giulia, Passarini Claudio, Rapezzi Gianluca, Campo |
author_facet | Matteo, Serenelli Anna, Cantone Federico, Sanguettoli Daniele, Maio Gioele, Fabbri Beatrice, Dal Passo Rita, Pavasini Elisabetta, Tonet Giulia, Passarini Claudio, Rapezzi Gianluca, Campo |
author_sort | Matteo, Serenelli |
collection | PubMed |
description | BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier phases and does not represent well the pathophysiology of CA. Many echocardiographic parameters resulted important diagnostic and prognostic tools in patients with CA. Stroke volume (SV) and myocardial contraction fraction (MCF) may be obtained both with echocardiography and cardiac magnetic resonance (MRI). They reflect many factors intrinsically related to the pathophysiology of CA and are therefore potentially associated with symptoms and prognosis in CA. OBJECTIVES: To collect and summarize the current evidence on SV and MCF and their clinical and prognostic role in transthyretin (TTR-CA). METHODS AND RESULTS: We performed a systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature database for studies focusing on SV and MCF in patients with TTR-CA. We analysed the following databases: PUBMED, Cochrane Library, EMBASE, and Web of Science database. Fourteen studies were included in the review. Both SV and MCF have important prognostic implications and are related to mortality. Furthermore, SV is more related to symptoms than LVEF and predicts tolerability of beta-blocker therapy in TTR-CA. Finally, SV showed to be an excellent measure to suggest the presence of TTR-CA in patients with severe aortic stenosis. CONCLUSION: Stroke volume and MCF are very informative parameters that should be routinely assessed during the standard echocardiographic examination of all patients with TTR-CA. They carry a prognostic role while being associated with patients’ symptoms. SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.17605/OSF.IO/ME7DS. |
format | Online Article Text |
id | pubmed-9911429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99114292023-02-11 Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review Matteo, Serenelli Anna, Cantone Federico, Sanguettoli Daniele, Maio Gioele, Fabbri Beatrice, Dal Passo Rita, Pavasini Elisabetta, Tonet Giulia, Passarini Claudio, Rapezzi Gianluca, Campo Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier phases and does not represent well the pathophysiology of CA. Many echocardiographic parameters resulted important diagnostic and prognostic tools in patients with CA. Stroke volume (SV) and myocardial contraction fraction (MCF) may be obtained both with echocardiography and cardiac magnetic resonance (MRI). They reflect many factors intrinsically related to the pathophysiology of CA and are therefore potentially associated with symptoms and prognosis in CA. OBJECTIVES: To collect and summarize the current evidence on SV and MCF and their clinical and prognostic role in transthyretin (TTR-CA). METHODS AND RESULTS: We performed a systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature database for studies focusing on SV and MCF in patients with TTR-CA. We analysed the following databases: PUBMED, Cochrane Library, EMBASE, and Web of Science database. Fourteen studies were included in the review. Both SV and MCF have important prognostic implications and are related to mortality. Furthermore, SV is more related to symptoms than LVEF and predicts tolerability of beta-blocker therapy in TTR-CA. Finally, SV showed to be an excellent measure to suggest the presence of TTR-CA in patients with severe aortic stenosis. CONCLUSION: Stroke volume and MCF are very informative parameters that should be routinely assessed during the standard echocardiographic examination of all patients with TTR-CA. They carry a prognostic role while being associated with patients’ symptoms. SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.17605/OSF.IO/ME7DS. Frontiers Media S.A. 2023-01-27 /pmc/articles/PMC9911429/ /pubmed/36776259 http://dx.doi.org/10.3389/fcvm.2023.1085824 Text en Copyright © 2023 Matteo, Anna, Federico, Daniele, Gioele, Beatrice, Rita, Elisabetta, Giulia, Claudio and Gianluca. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Matteo, Serenelli Anna, Cantone Federico, Sanguettoli Daniele, Maio Gioele, Fabbri Beatrice, Dal Passo Rita, Pavasini Elisabetta, Tonet Giulia, Passarini Claudio, Rapezzi Gianluca, Campo Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title | Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title_full | Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title_fullStr | Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title_full_unstemmed | Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title_short | Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review |
title_sort | stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: a systematic review |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911429/ https://www.ncbi.nlm.nih.gov/pubmed/36776259 http://dx.doi.org/10.3389/fcvm.2023.1085824 |
work_keys_str_mv | AT matteoserenelli strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT annacantone strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT federicosanguettoli strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT danielemaio strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT gioelefabbri strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT beatricedalpasso strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT ritapavasini strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT elisabettatonet strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT giuliapassarini strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT claudiorapezzi strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview AT gianlucacampo strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview |